NOT-FD-23-011: Notice to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed

Notice to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed

Notice Number:

NOT-FD-23-011

Key Dates

Release Date:

April 14, 2023

Related Announcements

January 24, 2023 - Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed. See NOFO RFA-FD-23-027.

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

This Notice is to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed

New Application Due Date(s)

April 21, 2023, by 11:59 PM Eastern Time.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.

Late applications will not be accepted for this FOA.

Inquiries

Please direct all inquiries to:

Janelle Fundersburg
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: Janelle.Fundersburg@fda.hhs.gov